Page 378 - IJB-10-6
P. 378

International Journal of Bioprinting                                           3D-printed NAFLD model




            impacting hepatic detoxification capacity. The experimental   a promising platform for in vitro drug screening and research
            findings align with most of the literature reporting decreased   on liver disease mechanisms, which contributes to a deeper
            secretion of CYP450 enzymes in NAFLD patients, affecting   understanding of  NAFLD  and  facilitates the development
            drug metabolism and excretion. 34                  of related pharmaceuticals and therapeutic strategies.
                                                               Furthermore, in future studies, liver sinusoidal endothelial
            3.5. 3D-printed NAFLD model application:           cells, stellate cells, and Kupffer cells can be used to gain a
            Prevention and reversibility                       more comprehensive understanding of NAFLD.
            The 3D-printed NAFLD model was used for drug testing,
            and ELA (a PPARα and PPARδ agonist) was selected   Acknowledgments
            due to its positive efficacy in both animal studies and in
            vitro cell experiments. 35,36  The therapeutic effects of ELA   None.
            for the prevention and reversal of NAFLD were studied
            in 3D-printed NAFLD models. For NAFLD prevention,   Funding
            ELA and lipogenic medium were added simultaneously   This research was funded by the Natural Science Foundation
            (Figure 5A). ELA (10 or 30 μM) was used to prevent NAFLD,   of Hubei Province (grant number 2023AFB411) and the
            and both ELA dosages had no significant effect on the cell   Knowledge Innovation Project of Wuhan Science and
            survival rate (Figure 5B), whereas 30 μM ELA prevented   Technology Bureau (grant number 2023020201020532).
            intracellular  lipid  accumulation  (lipid  accumulation  was
            close to that of the control group) (Figure 5C and D). For   Conflict of interest
            NAFLD reversal, lipogenic medium was added to induce   The authors declare no conflicts of interest.
            NAFLD, which was then replaced with medium containing
            10 or 30 μM ELA to reverse NAFLD (Figure 5E). Moreover,   Author contributions
            10 and 30 μM ELA did not affect the cell survival rate
            (Figure 5F), whereas 30  μM ELA reversed intracellular   Conceptualization: Jing Liu
            lipid  accumulation  (the  lipid  accumulation  was  close  to   Formal analysis: Tao Ding, Tianma He
            that of the control group) (Figure 5G and H). Notably, ELA   Investigation: Kun Du, Wei Peng, Zibei Ming
            is a PPARα and PPARδ agonist that has beneficial effects   Methodology: Feifei Pu, Ying Zhao, Renquan Ruan
            on lipid metabolism according to the literature. 37,38  In this   Writing – original draft: Kun Du, Wei Peng
            study, ELA was used as an example to verify the feasibility   Writing – review & editing: Jing Liu
            of  this  platform  for  studying  NAFLD  drugs,  suggesting
            that both prevention and reversal of NAFLD could be   Ethics approval and consent participate
            replicated on the platform. Owing to the highly biomimetic   Not applicable.
            3D-printed liver tissue, physiologically similar physical and
            chemical microenvironments, and more accurate NAFLD   Consent for publication
            modeling, the NAFLD model proposed in this study can
            be used as a promising platform for in vitro drug screening   Not applicable.
            and liver disease mechanism research.
                                                               Availability of data
            4. Conclusion                                      Data  is  available  from  the  corresponding  author  upon
            In this study, a functional NAFLD model was successfully   reasonable request.
            constructed via 3D bioprinting technology. Large-scale
            liver tissue with vascular-like functions was created in vitro   References
            through bioink optimization and the induction of HepaRG   1.   Lazarus  JV,  Mark  HE,  Villota-Rivas  M,  et  al.  The  global
            cells  to  form  liver  organoids.  Compared  with  traditional   NAFLD policy review and preparedness index: are countries
            models, 3D-printed liver tissue exhibited superior hepatic   ready to address this silent public health challenge? J Hepatol.
            functions and greater cell viability; glycogen storage and the   2022;76(4):771-780.
            formation of bile canaliculi-like structures were also observed      doi: 10.1016/j.jhep.2021.10.025
            within it. The induced NAFLD model displayed significant   2.   Sozen E, Demirel-Yalciner T, Sari D, Ozer NK. Cholesterol
            lipid droplet accumulation in the NAFLD induction     accumulation in hepatocytes mediates IRE1/p38 branch
            medium, and the concentration of FFAs influenced this   of endoplasmic reticulum stress to promote nonalcoholic
            accumulation. Importantly, the induction medium had no   steatohepatitis. Free Radic Biol Med. 2022;191:1-7.
            significant effect on cell viability. Overall, this study provides      doi: 10.1016/j.freeradbiomed.2022.08.024

            Volume 10 Issue 6 (2024)                       370                                doi: 10.36922/ijb.4312
   373   374   375   376   377   378   379   380   381   382   383